These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 1695859

  • 21. Loperamide inhibits tachykinin NK3-receptor-triggered serotonin release without affecting NK2-receptor-triggered serotonin release from guinea pig colonic mucosa.
    Kojima S, Ikeda M, Kamikawa Y.
    J Pharmacol Sci; 2005 Jun; 98(2):175-80. PubMed ID: 15942125
    [Abstract] [Full Text] [Related]

  • 22. Evidence for involvement of 5-hydroxytryptamine1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-second behavior.
    Marek GJ, Li AA, Seiden LS.
    J Pharmacol Exp Ther; 1989 Jul; 250(1):60-71. PubMed ID: 2746511
    [Abstract] [Full Text] [Related]

  • 23. Neurochemical mediators of the behavioural effects of receptor-selective substance P agonists administered intrathecally in the rat.
    Papir-Kricheli D, Gilon C, Chorev M, Selinger Z, Devor M.
    Neuropharmacology; 1990 Nov; 29(11):1055-65. PubMed ID: 1708112
    [Abstract] [Full Text] [Related]

  • 24. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
    Germonpré PR, Joos GF, Pauwels RA.
    Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
    [Abstract] [Full Text] [Related]

  • 25. Roles of dopamine and 5-hydroxytryptamine in stereotyped and non-stereotyped behaviour.
    Dickinson SL, Curzon G.
    Neuropharmacology; 1983 Jul; 22(7):805-12. PubMed ID: 6225959
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Neurokinin A and senktide attenuate scopolamine-induced impairment of spontaneous alternation performance in mice.
    Ukai M, Shinkai N, Kameyama T.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Jun; 16(3):97-101. PubMed ID: 8905797
    [Abstract] [Full Text] [Related]

  • 28. Bronchoconstrictor effect of the tachykinin NK₃-receptor agonists [MePhe⁷]-neurokinin B and senktide in the isolated guinea pig lung.
    Corboz MR, Rivelli MA, Eckel SP.
    Exp Lung Res; 2010 Nov; 36(9):509-21. PubMed ID: 20939761
    [Abstract] [Full Text] [Related]

  • 29. The effects of lesions produced by 5,7-dihydroxytryptamine on 5-hydroxytryptamine-mediated behaviour induced by amphetamine in large doses in the rat.
    Dickinson SL, Andrews CD, Curzon G.
    Neuropharmacology; 1984 Apr; 23(4):423-9. PubMed ID: 6728129
    [Abstract] [Full Text] [Related]

  • 30. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ, Bervoets K, Colpaert FC.
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [Abstract] [Full Text] [Related]

  • 31. The tachykinin NH2-senktide inhibits alcohol intake in alcohol-preferring rats.
    Perfumi M, Polidori C, Pompei PL, De Caro G, Massi M.
    Pharmacol Biochem Behav; 1991 Apr; 38(4):881-7. PubMed ID: 1714609
    [Abstract] [Full Text] [Related]

  • 32. Effect of morphine on 'wet-dog' shakes caused by cerebroventricular injection of serotonin.
    Drust EG, Sloviter RS, Connor JD.
    Pharmacology; 1979 Apr; 18(6):299-305. PubMed ID: 573908
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Serotonin regulation of tachykinin biosynthesis in the rat neostriatum.
    Walker PD, Riley LA, Hart RP, Jonakait GM.
    Brain Res; 1991 Apr 12; 546(1):33-9. PubMed ID: 1713119
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effect of 5-hydroxytryptamine3 receptor agonists on phosphoinositides hydrolysis in the rat fronto-cingulate and entorhinal cortices.
    Edwards E, Harkins K, Ashby CR, Wang RY.
    J Pharmacol Exp Ther; 1991 Mar 12; 256(3):1025-32. PubMed ID: 1848625
    [Abstract] [Full Text] [Related]

  • 39. A pharmacological analysis of the hyperactivity syndrome induced by beta-phenylethylamine in the mouse.
    Dourish CT.
    Br J Pharmacol; 1982 Sep 12; 77(1):129-39. PubMed ID: 6982090
    [Abstract] [Full Text] [Related]

  • 40. Study of SR 142801, a new potent non-peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea-pig.
    Roccon A, Marchionni D, Nisato D.
    Br J Pharmacol; 1996 Jul 12; 118(5):1095-102. PubMed ID: 8818331
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.